During the past decade, Eagle's Landing Diabetes and Endocrinology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eagle's Landing Diabetes and Endocrinology" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Eagle's Landing Diabetes and Endocrinology" are "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Eagle's Landing Diabetes and Endocrinology" in a lesser frequency.

Most popular intervention types in "Eagle's Landing Diabetes and Endocrinology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (1 trials), "Empagliflozin high dose" (1 trials), "Empagliflozin low dose" (1 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eagle's Landing Diabetes and Endocrinology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Eagle's Landing Diabetes and Endocrinology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Eagle's Landing Diabetes and Endocrinology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eagle's Landing Diabetes and Endocrinology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".